These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 34987911

  • 1. A Rare Case of Pelvic Organ Prolapse in a Nulliparous Female With Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Polycystic Liver Disease (PLD).
    Hechter S, Ganta N, Kochhar S, Kanukuntla A, Kata P, Turro J, Cheriyath P.
    Cureus; 2021 Nov; 13(11):e20023. PubMed ID: 34987911
    [Abstract] [Full Text] [Related]

  • 2. Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis.
    Sierks D, Schönauer R, Friedrich A, Hantmann E, de Fallois J, Linder N, Fischer J, Herber A, Bergmann C, Berg T, Halbritter J.
    JHEP Rep; 2022 Nov; 4(11):100579. PubMed ID: 36246085
    [Abstract] [Full Text] [Related]

  • 3. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.
    Cnossen WR, Drenth JP.
    Orphanet J Rare Dis; 2014 May 01; 9():69. PubMed ID: 24886261
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease.
    Martin WP, Vaughan LE, Yoshida K, Takahashi N, Edwards ME, Metzger A, Senum SR, Masyuk TV, LaRusso NF, Griffin MD, El-Zoghby Z, Harris PC, Kremers WK, Nagorney DM, Kamath PS, Torres VE, Hogan MC.
    Mayo Clin Proc Innov Qual Outcomes; 2019 Jun 01; 3(2):149-159. PubMed ID: 31193902
    [Abstract] [Full Text] [Related]

  • 7. Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease.
    Kim H, Park HC, Ryu H, Kim K, Kim HS, Oh KH, Yu SJ, Chung JW, Cho JY, Kim SH, Cheong HI, Lee K, Park JH, Pei Y, Hwang YH, Ahn C.
    PLoS One; 2015 Jun 01; 10(12):e0144526. PubMed ID: 26641645
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fatal acute portal vein thrombosis associated with hepatic cysts in a patient with autosomal dominant polycystic kidney disease.
    Tsuchida Y, Tsubata Y, Nozawa R, Maruyama S, Ikarashi K, Saito N, Morioka T, Kamura T, Shimada H, Narita I.
    CEN Case Rep; 2024 Feb 01; 13(1):32-36. PubMed ID: 37162720
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Carbohydrate antigen 19-9 is significantly elevated in autosomal dominant polycystic kidney disease.
    Fukasawa H, Kaneko M, Niwa H, Yasuda H, Kumagai H, Furuya R.
    Nephrology (Carlton); 2018 Mar 01; 23(3):210-216. PubMed ID: 28024168
    [Abstract] [Full Text] [Related]

  • 16. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
    Hoevenaren IA, Wester R, Schrier RW, McFann K, Doctor RB, Drenth JP, Everson GT.
    Liver Int; 2008 Feb 01; 28(2):264-70. PubMed ID: 17927714
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis.
    Griffiths J, Mills MT, Ong AC.
    BMJ Open; 2020 Jan 09; 10(1):e032620. PubMed ID: 31924636
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.